Llwytho...

The use of a new combination of avelumab + axitinib in patients with metastatic kidney cancer in the first line of treatment

Introduction. Simultaneous inhibition of programmed cell death-1 (PD-1)/PD-L1 immune checkpoint and VEGF/VEGFR signaling has a  synergistic antitumor effect in  preclinical models. This article presents the  results of  the  phase III study JAVELIn Renal 101 (NCT02684006), as well as the experience...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: B. Ya. Alekseev, I. M. Shevchuk, V. Р. Aleshin
Fformat: Artigo
Iaith:Russo
Cyhoeddwyd: Remedium Group LLC 2021-06-01
Cyfres:Медицинский совет
Pynciau:
Mynediad Ar-lein:https://www.med-sovet.pro/jour/article/view/6209
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!